SIH Partners’s Amneal Pharmaceuticals AMRX Stock Holding History

SIH Partners’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-19,536	Closed	-$164K	–	176
2025 Q1	$164K	Buy	+19,536	New	+$163K	0.01%	235

Other funds holding AMRX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SIH Partners's AMRX Position: Q2 2025 in Review

SIH Partners sold out of Amneal Pharmaceuticals (AMRX) in Q2 2025, closing a stake of 19,536 shares — an estimated $164K sold.

SIH Partners first reported a position in AMRX in Q1 2025 and held it in 1 quarter. The position peaked at $164K in Q1 2025. 241 funds tracked by Wall St. Rank hold AMRX as of Q2 2025.

SIH Partners reported no remaining Amneal Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
SIH Partners sold 19,536 Amneal Pharmaceuticals shares in Q2 2025, an estimated $164K.
SIH Partners first reported a position in Amneal Pharmaceuticals in Q1 2025 and held it in 1 quarter.
SIH Partners's Amneal Pharmaceuticals position peaked at $164K in Q1 2025.
241 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2025.

Based on SIH Partners's 13F filing for Q2 2025, filed 14 Aug 2025.